Paper41363274
Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.
Widjaja AO and 11 others. Int J Cancer, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma. Papers, record 41363274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41363274
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ovarian Neoplasms | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Cystadenocarcinoma, Serous | Major topic |
| Mutation | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| High-Throughput Nucleotide Sequencing | |
| Aged | |
| Liquid Biopsy | |
| Biopsy | |
| Neoplasm Grading | |
| Adult | |
| Aged, 80 and over | |
| DNA Mutational Analysis | |
| Biomarkers, Tumor |
Source PubMed
Grants15
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021-01145 | Sjöbergstiftelsen | PubMed | ||
| 2020-0414 | Sweden innovation agency | PubMed | ||
| Kungliga vetenskaps och vitterhets-samhället | PubMed | |||
| Gunvor and Ivan Svensson foundation | PubMed | |||
| Nilsson-Ehle Endowments | PubMed | |||
| Lions Cancerfond väst | PubMed | |||
| FB22-67 | Stiftelsen Assar Gabrielssons Fond | PubMed | ||
| FB22-79 | Stiftelsen Assar Gabrielssons Fond | PubMed | ||
| FB23-118 | Stiftelsen Assar Gabrielssons Fond | PubMed | ||
| FB23-66 | Stiftelsen Assar Gabrielssons Fond | PubMed | ||
| Cancera foundation | PubMed | |||
| 21-1848 | Cancerfonden | PubMed | ||
| 22-2080 | Cancerfonden | PubMed | ||
| 965065 | Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement | PubMed | ||
| 965552 | Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30376484 | Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study. | Int J Gynecol Cancer | 2018 | https://conductscience.org/library/papers/30376484 | PubMed |
| 2 | 31471400 | Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution. | In Vivo | 2019 | https://conductscience.org/library/papers/31471400 | PubMed |
| 3 | 11745677 | Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. | J Pathol | 2001 | https://conductscience.org/library/papers/11745677 | PubMed |
| 4 | 20229506 | Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. | J Pathol | 2010 | https://conductscience.org/library/papers/20229506 | PubMed |
| 5 | 19628427 | Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. | J Clin Virol | 2009 | https://conductscience.org/library/papers/19628427 | PubMed |
| 6 | 39828035 | Optimization of Pre-Analytical Handling to Maintain DNA Integrity in Diagnostic Papanicolaou Tests. | J Mol Diagn | 2025 | https://conductscience.org/library/papers/39828035 | PubMed |
| 7 | 29563323 | Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/29563323 | PubMed |
| 8 | 31780779 | Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers. | Br J Cancer | 2020 | https://conductscience.org/library/papers/31780779 | PubMed |
| 9 | 7942844 | A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. | Am J Hum Genet | 1994 | https://conductscience.org/library/papers/7942844 | PubMed |
| 10 | 39115191 | Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer. | Mol Oncol | 2024 | https://conductscience.org/library/papers/39115191 | PubMed |
| 11 | 36031761 | UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers. | Clin Chem | 2022 | https://conductscience.org/library/papers/36031761 | PubMed |
| 12 | 32106643 | Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer. | Cancer Res Treat | 2020 | https://conductscience.org/library/papers/32106643 | PubMed |
| 13 | 27421040 | Diagnostic potential of tumor DNA from ovarian cyst fluid. | Elife | 2016 | https://conductscience.org/library/papers/27421040 | PubMed |
| 14 | 10435620 | p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. | Oncogene | 1999 | https://conductscience.org/library/papers/10435620 | PubMed |
| 15 | 32609349 | Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/32609349 | PubMed |
| 16 | 21720365 | Integrated genomic analyses of ovarian carcinoma. | Nature | 2011 | https://conductscience.org/library/papers/21720365 | PubMed |
| 17 | 29348365 | Detection and localization of surgically resectable cancers with a multi-analyte blood test. | Science | 2018 | https://conductscience.org/library/papers/29348365 | PubMed |
| 18 | 31664085 | Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method. | Sci Rep | 2019 | https://conductscience.org/library/papers/31664085 | PubMed |
| 19 | 5279523 | Mutation and cancer: statistical study of retinoblastoma. | Proc Natl Acad Sci U S A | 1971 | https://conductscience.org/library/papers/5279523 | PubMed |
| 20 | 21990067 | TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. | J Pathol | 2012 | https://conductscience.org/library/papers/21990067 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42015198 | Combining circulating tumor cell and circulating cell-free DNA analyses broadens clinical applicability of liquid biopsy in high grade serous tubo-ovarian carcinoma. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42015198 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41363274
GET https://conductscience.org/api/papers/v1/41363274/references?page=2